These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 30018088

  • 1. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
    Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, Jaumdally SZ, Williamson AL, Little F, Van Damme L, Ahmed K, Crucitti T, Abdellati S, Bekker LG, Gray G, Dietrich J, Jaspan H, Passmore JS.
    Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.
    Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JA.
    Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781
    [Abstract] [Full Text] [Related]

  • 3. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V.
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [Abstract] [Full Text] [Related]

  • 4. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
    Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L.
    Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
    [Abstract] [Full Text] [Related]

  • 5. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN, Morrison CS, Chen PL, Yamamoto HS, Govender Y, Junaid D, Ryan S, Kwok C, Chipato T, Salata RA, Doncel GF.
    PLoS One; 2020 Dec; 15(1):e0224359. PubMed ID: 31914129
    [Abstract] [Full Text] [Related]

  • 6. Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).
    Ramboarina S, Crucitti T, Gill K, Bekker LG, Harding-Esch EM, van de Wijgert JHHM, Huynh BT, Fortas C, Harimanana A, Mayouya Gamana T, Randremanana RV, Mangahasimbola R, Dziva Chikwari C, Kranzer K, Mackworth-Young CRS, Bernays S, Thomas N, Anderson D, Tanko FR, Manhanzva M, Lurie M, Khumalo F, Sinanovic E, Honda A, Pidwell T, Francis SC, Masson L, Passmore JA, GIFT study group.
    BMJ Open; 2024 May 01; 14(5):e084918. PubMed ID: 38692732
    [Abstract] [Full Text] [Related]

  • 7. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S, Barnabas SL, Lennard KS, Jaumdally SZ, Gamieldien H, Balle C, Happel AU, Murugan BD, Williamson AL, Mkhize N, Dietrich J, Lewis DA, Chiodi F, Hope TJ, Shattock R, Gray G, Bekker LG, Jaspan HB, Passmore JS.
    PLoS One; 2019 May 01; 14(4):e0213975. PubMed ID: 30947260
    [Abstract] [Full Text] [Related]

  • 8. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
    Taku O, Onywera H, Mbulawa ZZA, Businge CB, Meiring TL, Williamson AL.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0222921. PubMed ID: 35647888
    [Abstract] [Full Text] [Related]

  • 9. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
    Mngomezulu K, Mzobe GF, Mtshali A, Osman F, Liebenberg LJP, Garrett N, Singh R, Rompalo A, Mindel A, Karim SSA, Karim QA, Baxter C, Ngcapu S.
    Front Immunol; 2021 Jun 29; 12():695201. PubMed ID: 34177961
    [Abstract] [Full Text] [Related]

  • 10. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A, San JE, Osman F, Garrett N, Balle C, Giandhari J, Onywera H, Mngomezulu K, Mzobe G, de Oliveira T, Rompalo A, Mindel A, Abdool Karim SS, Ravel J, Passmore JS, Abdool Karim Q, Jaspan HB, Liebenberg LJP, Ngcapu S.
    Front Immunol; 2021 Jun 29; 12():730986. PubMed ID: 34594336
    [Abstract] [Full Text] [Related]

  • 11. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N, Andersch B, Falsen E, Strömbeck L, Mattsby-Baltzer I.
    APMIS; 2008 Apr 29; 116(4):263-77. PubMed ID: 18397461
    [Abstract] [Full Text] [Related]

  • 12. Analysis of bacterial vaginosis, the vaginal microbiome, and sexually transmitted infections following the provision of menstrual cups in Kenyan schools: Results of a nested study within a cluster randomized controlled trial.
    Mehta SD, Zulaika G, Agingu W, Nyothach E, Bhaumik R, Green SJ, van Eijk AM, Kwaro D, Otieno F, Phillips-Howard P.
    PLoS Med; 2023 Jul 29; 20(7):e1004258. PubMed ID: 37490459
    [Abstract] [Full Text] [Related]

  • 13. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R, Mayadeo N, Warke H, Begum S, Aich P, Aranha C.
    Microb Pathog; 2019 Sep 29; 134():103599. PubMed ID: 31212037
    [Abstract] [Full Text] [Related]

  • 14. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V, Obila O, Gajer P, Scott MC, Dizzell S, Humphrys M, Shahabi K, Huibner S, Shannon B, Tharao W, Mureithi M, Oyugi J, Kimani J, Kaushic C, Ravel J, Anzala O, Kaul R.
    Clin Infect Dis; 2019 May 02; 68(10):1675-1683. PubMed ID: 30407498
    [Abstract] [Full Text] [Related]

  • 15. Vaginal Microbiota and Mucosal Immune Markers in Women With Vulvovaginal Discomfort.
    Mitchell CM, Watson L, Mitchell AJ, Hyrien O, Bergerat A, Valint DJ, Pascale A, Hoffman N, Srinivasan S, Fredricks DN.
    Sex Transm Dis; 2020 Apr 02; 47(4):269-274. PubMed ID: 32044865
    [Abstract] [Full Text] [Related]

  • 16. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY, Throop AL, Herbst-Kralovetz MM.
    J Infect Dis; 2014 Jun 15; 209(12):1989-99. PubMed ID: 24403560
    [Abstract] [Full Text] [Related]

  • 17. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU, Singh R, Mitchev N, Mlisana K, Jaspan HB, Barnabas SL, Passmore JS.
    BMC Infect Dis; 2020 Jul 10; 20(1):491. PubMed ID: 32650729
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the vaginal microflora in health and disease.
    Datcu R.
    Dan Med J; 2014 Apr 10; 61(4):B4830. PubMed ID: 24814599
    [Abstract] [Full Text] [Related]

  • 19. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
    Alcaide ML, Rodriguez VJ, Brown MR, Pallikkuth S, Arheart K, Martinez O, Roach M, Fichorova RN, Jones DL, Pahwa S, Fischl MA.
    AIDS Res Hum Retroviruses; 2017 Apr 10; 33(4):309-317. PubMed ID: 27897054
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of a commercial multiplex PCR for the diagnosis of bacterial vaginosis.
    van der Veer C, van Houdt R, van Dam A, de Vries H, Bruisten S.
    J Med Microbiol; 2018 Sep 10; 67(9):1265-1270. PubMed ID: 29985123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.